Format

Send to

Choose Destination
Allergy. 2019 Jul;74(7):1219-1236. doi: 10.1111/all.13701. Epub 2019 Apr 30.

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.

Bosnic-Anticevich S1, Costa E2, Menditto E3, Lourenço O4, Novellino E5, Bialek S6, Briedis V7, Buonaiuto R8, Chrystyn H9, Cvetkovski B1, Di Capua S10, Kritikos V1, Mair A11, Orlando V3, Paulino E12, Salimäki J13, Söderlund R14, Tan R1, Williams DM15, Wroczynski P6, Agache I16, Ansotegui IJ17, Anto JM18,19,20,21, Bedbrook A22, Bachert C23, Bewick M24, Bindslev-Jensen C25, Brozek JL26, Canonica GW27, Cardona V28, Carr W29, Casale TB30, Chavannes NH31, Correia de Sousa J32,33, Cruz AA34,35, Czarlewski W36, De Carlo G37, Demoly P38,39, Devillier P40, Dykewicz MS41, Gaga M42, El-Gamal Y43, Fonseca J44,45, Fokkens WJ46, Guzmán MA47, Haahtela T48,49, Hellings PW50, Illario M51, Ivancevich JC52, Just J53, Kaidashev I54, Khaitov M55, Khaltaev N56, Keil T57,58, Klimek L59, Kowalski ML60, Kuna P61, Kvedariene V62, Larenas-Linnemann DE63, Laune D64, Le LTT65, Lodrup Carlsen KC66,67, Mahboub B68, Maier D69, Malva J70,71, Manning PJ72, Morais-Almeida M73, Mösges R74,75, Mullol J76, Münter L77, Murray R78, Naclerio R79, Namazova-Baranova L80, Nekam K81, Nyembue TD82, Okubo K83, O'Hehir RE84,85, Ohta K86, Okamoto Y87, Onorato GL22, Palkonen S37, Panzner P88, Papadopoulos NG89,90, Park HS91, Pawankar R92, Pfaar O93, Phillips J94, Plavec D95, Popov TA96, Potter PC97, Prokopakis EP98, Roller-Wirnsberger RE99, Rottem M100, Ryan D101, Samolinski B102, Sanchez-Borges M103,104, Schunemann HJ26, Sheikh A105, Sisul JC106, Somekh D107, Stellato C108, To T109, Todo-Bom AM110,111, Tomazic PV112, Toppila-Salmi S48,49, Valero A113, Valiulis A114,115, Valovirta E116, Ventura MT117, Wagenmann M118, Wallace D119, Waserman S120, Wickman M121, Yiallouros PK122,123, Yorgancioglu A124, Yusuf OM125, Zar HJ126, Zernotti ME127, Zhang L128, Zidarn M129, Zuberbier T130, Bousquet J22,130,131,132,133,134.

Author information

1
Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia.
2
UCIBIO, REQUIMTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal.
3
CIRFF, Federico II University, Naples, Italy.
4
Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
5
Department of Pharmacy of University of Naples Federico II, Naples, Italy.
6
Department of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, Warsaw, Poland.
7
Department of Clinical Pharmacy of Lithuanian, University of Health Sciences, Kaunas, Lithuania.
8
Pharmacist, Municipality Pharmacy, Sarno, Italy.
9
RiRL, Oakington, Cambridge, UK.
10
Farmacie Dei Golfi Group, Massa Lubrense, Italy.
11
DG for Health and Social Care, Scottish Government, Edinburgh, UK.
12
Farmacias Holon, Lisbon, Portugal.
13
Association of Finnish Pharmacies, Helsinki, Finland.
14
Department of Nephrology and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
15
Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina.
16
Transylvania University Brasov, Brasov, Romania.
17
Department of Allergy and Immunology, Hospital Quirón Bizkaia, Erandio, Spain.
18
ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
19
IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
20
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
21
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
22
MACVIA-France, Fondation Partenariale FMC VIA-LR, Montpellier, France.
23
Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
24
iQ4U Consultants Ltd, London, UK.
25
Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
26
Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
27
Personalized Medicine Clinic Asthma & Allergy, Humanitas Research Hospital, Humanitas University, Rozzano, Milan, Italy.
28
Allergy Section, Department of Internal Medicine, Hospital Vall 'dHebron & ARADyAL Research Network, Barcelona, Spain.
29
Allergy and Asthma Associates of Southern California, Mission Viejo, California.
30
Division of Allergy/Immunology, University of South Florida, Tampa, Florida.
31
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
32
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
33
ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
34
ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
35
WHO GARD Planning Group, Brasilia, Brazil.
36
Medical Consulting Czarlewski, Levallois, France.
37
EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
38
Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
39
Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, Medical School Saint Antoine, INSERM and UPMC Sorbonne Université, Paris, France.
40
Laboratoire de Pharmacologie Respiratoire UPRES EA220, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Université Paris Saclay, Saclay, France.
41
Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri.
42
ERS President 2017-2018, Athens Chest Hospital, 7th Resp Med Department and Asthma Center, Athens, Greece.
43
Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
44
CINTESIS, Center for Research in Health Technologies and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
45
MEDIDA, Lda, Porto, Portugal.
46
Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
47
Immunology and Allergy Division, Clinical Hospital, University of Chile, Santiago, Chile.
48
Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
49
University of Helsinki, Helsinki, Finland.
50
Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
51
Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
52
Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
53
Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
54
Ukrainian Medical Stomatological Academy, Poltava, Ukraine.
55
National Research Center, Institute of Immunology, Federal Medicobiological Agency, Laboratory of Molecular immunology, Moscow, Russian Federation.
56
GARD Chairman, Geneva, Switzerland.
57
Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
58
Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
59
Center for Rhinology and Allergology, Wiesbaden, Germany.
60
Department of Immunology and Allergy, Healthy Ageing Research Center, Medical University of Lodz, Lodz, Poland.
61
Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
62
Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
63
Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
64
KYomed INNOV, Montpellier, France.
65
University of Medicine and Pharmacy, Hochiminh City, Vietnam.
66
Department of Paediatrics, Oslo University Hospital, Oslo, Norway.
67
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
68
Department of Pulmonary Medicine, Rashid Hospital, Dubai, UAE.
69
Biomax Informatics AG, Munich, Germany.
70
Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.
71
Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
72
Department of Medicine (RCSI), Bon Secours Hospital, Glasnevin, Dublin, Ireland.
73
Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
74
Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany.
75
CRI-Clinical Research International-Ltd, Hamburg, Germany.
76
Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
77
Danish Committee for Health Education, Copenhagen East, Denmark.
78
MedScript Ltd, Dundalk, Co Louth, Ireland.
79
Johns Hopkins School of Medicine, Baltimore, Maryland.
80
Scientific Centre of Children's Health under the MoH, Russia, Russian National Research Medical University named Pirogov, Moscow, Russia.
81
Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.
82
ENT Department, University Hospital of Kinshasa, Kinshasa, Congo.
83
Department of Otolaryngology, Nippon Medical School, Tokyo, Japan.
84
Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
85
Department of Immunology, Monash University, Melbourne, Victoria, Australia.
86
National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
87
Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
88
Department of Immunology and Allergology, Faculty of Medicine and Faculty Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
89
Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
90
Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
91
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea.
92
Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
93
Department of Otorhinolaryngology, Head and Neck Surgery, Section for Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
94
Centre for Empowering Patients and Communities, Faulkland, Somerset, UK.
95
Children's Hospital Srebrnjak, Zagreb, School of Medicine, University J.J. Strossmayer, Osijek, Croatia.
96
University Hospital 'Sv Ivan Rilski'", Sofia, Bulgaria.
97
Allergy Diagnostic and Clinical Research Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
98
Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece.
99
Department of Internal Medicine, Medical University of Graz, Graz, Austria.
100
Division of Allergy Asthma and Clinical Immunology, Emek Medical Center, Afula, Israel.
101
Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Past President SLAAI, FACAAI, Edinburgh, UK.
102
Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
103
Allergy and Clinical Immunology Department, Centro Médico-Docente la Trinidad, Caracas, Trinidad.
104
Clínica El Avila, Altamira, Caracas, Venezuela.
105
The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
106
Sociedad Paraguaya de Alergia Asma e Inmunologie, Asuncion, Paraguay.
107
European Health Futures Forum (EHFF), Isle of Wright, UK.
108
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
109
The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
110
Imunoalergologia, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
111
Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
112
Department of ENT, Medical University of Graz, Graz, Austria.
113
Pneumology and Allergy Department CIBERES and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain.
114
Clinic of Children's Diseases and Institute of Health Sciences, Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
115
European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
116
Department of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo allergy clinic, Turku, Finland.
117
Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
118
Department of Otorhinolaryngology, Universitätsklinikum Düsseldorf, Dusseldorf, Germany.
119
Nova Southeastern University, Fort Lauderdale, Florida.
120
Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.
121
Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
122
Cyprus International Institute for Environmenta & Public Health in Association with Harvard School of Public Health, Cyprus University of Technology, Limassol, Cyprus.
123
Department of Pediatrics, Hospital "Archbishop Makarios III", Nicosia, Cyprus.
124
Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
125
The Allergy and Asthma Institute, Islamabad, Pakistan.
126
Department of Paediatrics and Child Health, Red Cross Children's, Hospital, and MRC Unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.
127
Universidad Católica de Córdoba, Córdoba, Argentina.
128
Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Beijing Institute of Otolaryngology, Beijing, China.
129
University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
130
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, A member of GA2LEN, Berlin, Germany.
131
University Hospital, Montpellier, France.
132
INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and public health approaches, Villejuif, France.
133
Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
134
Euforea, Brussels, Belgium.

Abstract

Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.

KEYWORDS:

Allergic Rhinitis and its Impact on Asthma ; Asthma; Care pathways; Pharmacist; Rhinitis

PMID:
30565275
DOI:
10.1111/all.13701

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center